🔗 Share this article

Texas Attorney General Ken Paxton is suing the producers of acetaminophen, alleging the corporations concealed potential risks that the pain reliever posed to pediatric cognitive development.

This legal action arrives thirty days after President Donald Trump publicized an unverified association between consuming Tylenol - referred to as paracetamol - during pregnancy and autism spectrum disorder in children.

The attorney general is filing suit against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which presently makes it.

In a official comment, he said they "deceived the public by gaining financially from pain and marketing drugs ignoring the dangers."

The company asserts there is no credible evidence linking Tylenol to autism spectrum disorder.

"These companies deceived for years, deliberately risking millions to line their pockets," the attorney general, from the Republican party, declared.

The company commented that it was "very worried by the dissemination of inaccurate information on the safety of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its official site, Kenvue also stated it had "consistently assessed the pertinent research and there is no credible data that shows a proven link between using paracetamol and autism spectrum disorder."

Associations representing physicians and medical practitioners concur.

ACOG has stated acetaminophen - the key substance in acetaminophen - is one of the few options for women during pregnancy to manage pain and fever, which can present serious health risks if ignored.

"In more than two decades of research on the use of acetaminophen in gestation, no reliable research has successfully concluded that the use of acetaminophen in any stage of gestation causes neurological conditions in children," the group stated.

The court filing mentions latest statements from the former administration in asserting the drug is reportedly hazardous.

In recent weeks, Trump caused concern from health experts when he advised pregnant women to "struggle intensely" not to use Tylenol when ill.

The US Food and Drug Administration then issued a notice that doctors should think about restricting the usage of acetaminophen, while also declaring that "a proven link" between the drug and autism in minors has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the Food and Drug Administration, had pledged in spring to undertake "comprehensive study program" that would identify the source of autism spectrum disorder in a matter of months.

But specialists cautioned that identifying a single cause of autism spectrum disorder - thought by researchers to be the result of a complex mix of genetic and environmental factors - would be difficult.

Autism spectrum disorder is a category of lifelong neurodivergence and disability that impacts how persons experience and relate to the world, and is recognized using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is seeking the Senate - claims the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the research" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the corporations "remove any marketing or advertising" that states Tylenol is reliable for women during pregnancy.

The Texas lawsuit echoes the concerns of a assembly of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in two years ago.

Judicial authorities rejected the lawsuit, stating studies from the plaintiffs' authorities was inconclusive.